← Open Payments lookup

KIMBERLY WHITBECK-DRAKE: Open Payments

NPI 1639786981 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$446 in 23 payments from 10 companies in 2025. Trend: 2023 $338 · 2024 $607 · 2025 $446

Food & beverage: $446
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation5$109
Amgen Inc.4$70
AstraZeneca Pharmaceuticals LP3$49
ABIOMED2$44
Edwards Lifesciences Corporation1$42
Esperion Therapeutics, Inc.2$33
SCPHARMACEUTICALS INC.2$33
PFIZER INC.2$33
Novo Nordisk Inc1$18
Lilly USA, LLC1$15

Products named: LEQVIO, REPATHA, FARXIGA, PASCAL, NEXLETOL, FUROSCIX, ELIQUIS, Wegovy.

Industry payments across NY — which companies pay providers there.